Device Trial Radar · NCT00713557
Shanghai Registry of Acute Coronary Events
Last checked: Nov 19, 2026Latest source record: Oct 13, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
20,000
Planned (sponsor's estimate)
Start
Mar 2005
Primary completion
Jan 2018
Sponsor
- Lead sponsor
- Shanghai Jiao Tong University School of MedicineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Ministry of Science and Technology of the People´s Republic of China; Changhai Hospital
- First posted
- Jul 11, 2008
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
SRACE is an multicenter observational database of outcomes for patients who are hospitalized with an acute coronary events. SRACE includes over 20 hospitals in Shanghai China that have enrolled a total of more than 3,000 patients since 2005, with an annual enrollment of 500 patients. The major purpose of the SRACE program is to evaluate the prognosis of patients admitted to the hospital due to acute coronary events, comparing different therapeutic strategies, in-hospital transferring system, and so on. All participating physicians receive confidential quarterly reports showing ther outcomes side-by-side with the aggregate outcomes of all participating hospitals.
Conditions
- Coronary Artery Disease
- Acute Coronary Syndrome
Interventions
drug-eluting stentDevice
drug-eluting stent, including sirolimus-eluting, paclitaxel-eluting and other types of China-made drug-eluting stent
TirofibanDrug
upstream (in emergency room) versus downstream (in catheterization lab) intra-coronary loading versus conventional intravenous loading
Primary outcomes
What the sponsor says the trial is designed to measure.
- major adverse cardiac events(MACE), including death, non-fatal re-MI, and target vessel revascularizationTime frame: in-hospital, 30d, and long-term follow-up
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Dept. of Cardiology, Ruijin Hospital
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.